Igor Matushansky insider trades

Open-market stock purchases and sales by Igor Matushansky, Chief Medical Officer at Immuneering Corp, from SEC Form 4 filings since Apr 17, 2019.

Recent trades

DateStockTradeValue
Feb 3, 2026IMRX Immuneering CorpBought (not open market)—

Companies traded

  • IMRX Immuneering Corp: other filings, last Feb 3, 2026
  • HOOK HOOKIPA Pharma Inc: 9 sales, last Jun 30, 2022

Get free alerts when Igor Matushansky files a new trade →